Kramer Robin bought BIIB

February 8, 2024 · Form 4 insider transaction

Kramer Robin bought 788 shares of Biogen Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 1 day after the transaction.

Direction

Acquired (buy-side)

788

Price

$0.00

Total value

N/A

InsiderKramer Robin

Role—

CompanyBiogen Inc. (BIIB)

SecurityCommon Stock

Transaction codeM — Option exercise

Transaction dateFebruary 8, 2024

Filing dateFebruary 9, 2024

Shares owned after4,943

OwnershipDirect

10b5-1 planNo

AmendedNo

View the original Form 4 on SEC EDGAR